Novel cannabinoid receptorsBROWN, A. J.British journal of pharmacology. 2007, Vol 152, Num 5, pp 567-575, issn 0007-1188, 9 p.Article

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity onlyFRIDE, Ester; FEIGIN, Cfir; PONDE, Datta E et al.European journal of pharmacology. 2004, Vol 506, Num 2, pp 179-188, issn 0014-2999, 10 p.Article

Pharmacological and therapeutic targets for Δ⁹-tetrahydrocannabinol and cannabidiolPERTWEE, Roger G.Euphytica. 2004, Vol 140, Num 1-2, pp 73-82, issn 0014-2336, 10 p.Conference Paper

Constitutive activity of cannabinoid-2 (CB₂) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242MANCINI, I; BRUSA, R; QUADRATO, G et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 382-391, issn 0007-1188, 10 p.Article

Targeting the cannabinoid CB2 receptor : modelling and structural determinants of CB2 selective ligandsPOSO, A; HUFFMAN, J. W.British journal of pharmacology. 2008, Vol 153, Num 2, pp 335-346, issn 0007-1188, 12 p.Article

Scaffold hopping strategy toward original pyrazolines as selective CB₂ receptor ligandsGEMBUS, Vincent; FURMAN, Christophe; MILLET, Regis et al.European journal of medicinal chemistry. 2012, Vol 58, pp 396-404, issn 0223-5234, 9 p.Article

A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activationD'ANTONA, Aaron M; AHN, Kwang H; LEI WANG et al.Brain research. 2006, Vol 1108, pp 1-11, issn 0006-8993, 11 p.Article

Pharmacological actions of cannabinoidsPERTWEE, R. G.Handbook of experimental pharmacology. 2005, Vol 168, pp 1-51, issn 0171-2004, 51 p.Article

Similar in vitro pharmacology of human cannabinoid CB₁ receptor variants expressed in CHO cellsJING CHEN XIAO; JEWELL, James P; LIN, Linus S et al.Brain research. 2008, Vol 1238, pp 36-43, issn 0006-8993, 8 p.Article

Inhibition of mouse lymphocyte 5'-nucleotidase by cannabinoids: a physical toxicity effectSADLER, M. C; SHAROM, F. J; MELLORS, A et al.Biochemical pharmacology. 1984, Vol 33, Num 10, pp 1685-1687, issn 0006-2952Article

CB₂ receptor-mediated migration of immune cells : it can go either wayMILLER, A. M; STELLA, N.British journal of pharmacology. 2008, Vol 153, Num 2, pp 299-308, issn 0007-1188, 10 p.Article

The role of the CB₁ receptor in the regulation of sleepMURILLO-RODRIGUEZ, Eric.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 6, pp 1420-1427, issn 0278-5846, 8 p.Article

Récepteurs cannabinoïdes: Fonctions cellulaires = Cannabinoid receptors : cellular functionsBOUABOULA, M; CASELLAS, P.Douleur et analgésie. 2001, Vol 14, Num 4, pp 207-211, issn 1011-288XArticle

Atypical cannabinoid stimulates endothelial cell migration via a G_i/G_o-coupled receptor distinct from CB₁, CB₂ or EDG-1FONG MING MO; OFFERTALER, Laszlo; KUNOS, George et al.European journal of pharmacology. 2004, Vol 489, Num 1-2, pp 21-27, issn 0014-2999, 7 p.Article

Endocannabinoids as positive or négative factors in hematopoietic cell migration and differentiationPATINKIN, Deborah; MILMAN, Garry; BREUER, Aviva et al.European journal of pharmacology. 2008, Vol 595, Num 1-3, pp 1-6, issn 0014-2999, 6 p.Article

The diverse CB₁ and CB₂ receptor pharmacology of three plant cannabinoids : Δ⁹-tetrahydrocannabinol, cannabidiol and Δ⁹-tetrahydrocannabivarinPERTWEE, R. G.British journal of pharmacology. 2008, Vol 153, Num 2, pp 199-215, issn 0007-1188, 17 p.Article

Cannabinoid-improgan cross-tolerance : Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid DB₁ receptorNALWALK, Julia W; SVOKOS, Konstantina; HOUGH, Lindsay B et al.European journal of pharmacology. 2006, Vol 549, Num 1-3, pp 79-83, issn 0014-2999, 5 p.Article

Effects of sample treatment on chromatographic analysis of cannabinoids in Cannabis sativa L. (Cannabaceae)TURNER, J. C; MAHLBERG, P. G.Journal of chromatography. 1984, Vol 283, pp 165-171, issn 0021-9673Article

Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cellsBARDELL, Tamera K; BARKER, Eric L.Neurochemistry international. 2010, Vol 57, Num 1, pp 76-83, issn 0197-0186, 8 p.Article

Endocannabinoids and the Neurochemistry of GluttonyKIRKHAM, Tim.Journal of neuroendocrinology. 2008, Vol 20, Num 9, pp 1099-1100, issn 0953-8194, 2 p.Article

Analysis of urine for 11-nor-△⁹-tetrahydrocannabinol-9-carboxylic acid using sep-PAK cartridges for sample cleanupNAKAMURA, G. R; STALL, W. J; MASTERS, R. G et al.Analytical chemistry (Washington, DC). 1985, Vol 57, Num 7, pp 1492-1494, issn 0003-2700Article

Oleamide: a member of the endocannabinoid family?FOWLER, Christopher J.British journal of pharmacology. 2004, Vol 141, Num 2, pp 195-196, issn 0007-1188, 2 p.Article

Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agentODAN, Masahide; ISHIZUKA, Natsuki; YASUI, Kiyoshi et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 8, pp 2898-2901, issn 0960-894X, 4 p.Article

Therapeutic potential of cannabinoids in CNS diseaseCROXFORD, J. Ludovic.CNS drugs. 2003, Vol 17, Num 3, pp 179-202, issn 1172-7047, 24 p.Article

CB₁ and CB₂ receptor-mediated signalling: a focus on endocannabinoidsMCALLISTER, Sean D; GLASS, Michelle.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 161-171, issn 0952-3278Article